全文获取类型
收费全文 | 5480198篇 |
免费 | 404491篇 |
国内免费 | 16959篇 |
专业分类
耳鼻咽喉 | 78885篇 |
儿科学 | 175906篇 |
妇产科学 | 149245篇 |
基础医学 | 803449篇 |
口腔科学 | 156935篇 |
临床医学 | 499805篇 |
内科学 | 1000289篇 |
皮肤病学 | 129485篇 |
神经病学 | 451109篇 |
特种医学 | 214181篇 |
外国民族医学 | 1428篇 |
外科学 | 824522篇 |
综合类 | 152433篇 |
现状与发展 | 25篇 |
一般理论 | 2942篇 |
预防医学 | 448581篇 |
眼科学 | 131346篇 |
药学 | 394537篇 |
28篇 | |
中国医学 | 14452篇 |
肿瘤学 | 272065篇 |
出版年
2021年 | 57506篇 |
2019年 | 59962篇 |
2018年 | 77728篇 |
2017年 | 59699篇 |
2016年 | 66344篇 |
2015年 | 78440篇 |
2014年 | 113092篇 |
2013年 | 179325篇 |
2012年 | 152063篇 |
2011年 | 162146篇 |
2010年 | 135024篇 |
2009年 | 133833篇 |
2008年 | 147915篇 |
2007年 | 160340篇 |
2006年 | 166877篇 |
2005年 | 161091篇 |
2004年 | 161701篇 |
2003年 | 151801篇 |
2002年 | 141099篇 |
2001年 | 216876篇 |
2000年 | 214305篇 |
1999年 | 191326篇 |
1998年 | 78212篇 |
1997年 | 72117篇 |
1996年 | 69813篇 |
1995年 | 65165篇 |
1994年 | 59296篇 |
1993年 | 54825篇 |
1992年 | 143346篇 |
1991年 | 138383篇 |
1990年 | 134496篇 |
1989年 | 131037篇 |
1988年 | 121635篇 |
1987年 | 119211篇 |
1986年 | 113254篇 |
1985年 | 110044篇 |
1984年 | 87677篇 |
1983年 | 76964篇 |
1982年 | 55109篇 |
1981年 | 50552篇 |
1980年 | 47594篇 |
1979年 | 79177篇 |
1978年 | 60454篇 |
1977年 | 53283篇 |
1976年 | 49296篇 |
1975年 | 52134篇 |
1974年 | 59143篇 |
1973年 | 56796篇 |
1972年 | 53955篇 |
1971年 | 50015篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Confounders contributing to the reported associations of coffee or caffeine with disease 总被引:2,自引:0,他引:2
G B Schreiber M Robins C E Maffeo M N Masters A P Bond D Morganstein 《Preventive medicine》1988,17(3):295-309
The role of caffeine or coffee in causing or promoting the incidence of serious disease is equivocal. Two design factors may account for the discrepancies in reported findings on the effects of coffee drinking: (a) imprecision of measurement and (b) confounding variables. A study of 2,714 white U.S. adults disclosed that, of 32 risk factors analyzed by linear and logistic regression, only sex and cigarette smoking were found to be important potential confounders of caffeine and coffee intake. Partial R2 values of the other 30 risk factors were relatively small and were inconsistent for each sex. It is unlikely that any of these factors could explain any of the reported associations between caffeine or coffee consumption and certain diseases. However, certain weak associations with caffeine or coffee intake should be included in the study design when they are known to be risk factors of a disease under investigation. These factors for men are dietary fat intake, vitamin C intake, and body mass index; and for women are vitamin use, alcohol intake, stress, and perceived health status. 相似文献
992.
Jay Magaziner Eleanor M. Simonsick T. Michael Kashner J. Richard Hebel 《Journal of clinical epidemiology》1988,41(11)
The present study evaluates the response comparability between 361 elderly hip fracture patients admitted from the community to seven Baltimore area hospitals between 1984 and 1986 and interviewer selected proxies on items pertaining to patients' pre-fracture health and functional status. Agreement across items ranges from very poor to good and varies with respect to the health or functional area assessed. Proxies tend to overestimate patient disability relative to the patients themselves, especially with regard to capacity to perform instrumental activities of daily living. Although proxies who report the greatest contact with patients respond most comparably to the patients, when they do disagree, proxies with the greatest patient contact tend to overestimate patient disability. The authors suggest that attention to item construction and phrasing may improve response comparability. 相似文献
993.
This article reports on a longitudinal qualitative study ofthe psychosocial factors influencing women's experience of breastfeeding.The findings illustrate the complex web of factors, both personaland environmental, that influence breastfeeding behaviour. Thesignificance of breastfeeding derives from the fact that it,in concert with the arrival of a new baby, heralds significantchanges in a woman's day-to-day life. Three major areas of change,in part precipitated by breastfeeding, were critical. Theseinclude changes in the amount of time available to the motherand the nature of the activities that fill this time, changesin a woman's body due to pregnancy and breastfeeding, and changesin the nature of a woman's personal needs. These changes constitutea substantial and often disconcerting shift in lifestyle. Thearticle examines the potential consequences of these changesfor the mother and the host of mediating factors that influenceher response to them and hence to breastfeeding. The mediatingfactors include the personal and psychological factors relatedto the attitudes, values and character traits of the mother,baby, and those close to them. Others are structural factorssuch as the absence or presence of formal and informal supportsystems that range from paid maternity leave to community drop-incentres, educational programmes, and community parks. They alsoinclude the host of cultural factors that influence the waysin which individuals and society view breastfeeding. 相似文献
994.
995.
Oil-emulsified (OE) and aqueous (Aq) vaccines were prepared with the same batch of inactivated A24 8345 foot and mouth disease virus (FMDV). Calves born to vaccinated dams did not respond to the Aq vaccine 30 or 90 days post partum. When the OE vaccine was used on a similar group of calves, no responses were elicited up to 21 days post partum. However, calves 30 or more days old responded like adult cattle to the OE vaccine. When the OE vaccine was used in colostral antibody-free calves 3-30 days old, all animals showed good antibody responses but, in calves vaccinated 3 or 7 days post partum, antibodies were detectable only after a considerable period of time. Our results show that both passively acquired colostral antibodies and age are important in the response of very young calves to FMDV oil vaccines. From a practical point of view, in endemic areas where adult cattle are periodically vaccinated, vaccination of calves between 30 and 60 days post partum with OE vaccines would lead to high levels of herd protection. 相似文献
996.
M J Buxton 《Health services management research》1988,1(1):43-50
Rapidly advancing health technology poses problems for managers. Although clear conceptual frameworks exist for economic evaluation, in practice severe problems remain in carrying out timely research that is locally appropriate to the needs of managers. This paper explores some of these problems in the context of the policy analysis interface between economic research and the management of technology. In the light of experience gained from recent evaluation research it indicates how researchers and managers can each contribute to the provision of a stronger empirical basis for policy making and policy management. An earlier version of this paper was presented at the joint meeting of the Health Economists Study Group and Institute of Health Service Management, University of York, 6-8 July 1987. The author would like to thank Christopher Spry and Mike Drummond for helpful comments. 相似文献
997.
Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors 总被引:1,自引:0,他引:1
Ninety-nine patients with primary recurrent malignant tumors of the central nervous system were treated with procarbazine as a single agent. Procarbazine was not given as a specified protocol, but for patients who were ineligible or refused other protocols. All patients had been treated previously with radiotherapy and 96 patients had also received previous chemotherapy. Twenty-five patients were treated at the first progression of their tumor, 47 were treated at the second progression, and 27 were treated at the third progression of their tumor. For the aggregate, the response plus stabilization rate was 27% for glioblastoma multiforme with median time to tumor progression of 30 weeks, and 28% for other anaplastic gliomas with a median time to tumor progression of 49 weeks. With respect to the percent of patients who responded or stabilized to treatment, these results are inferior to those reported previously for patients treated with procarbazine at recurrence. With respect to duration of response and stabilization, the data are comparable. 相似文献
998.
During recent decades there has been a controversial discussion if comparable plasma level profiles which are rather constant or those which show a high peak are more efficient for the cure of gonorrhoea. So far, investigations in this field were not based on the Grasso apparatus. Although the findings with cefotiam and ceftizoxime do not allow to formulate a general hypothesis without any restriction, it can be stated that on the basis of an identical area under the antibiotic level time curve, 'peak concentration' profiles are more favourable. 相似文献
999.
1000.
R. P. Heaney T. M. Zizic I. Fogelman W. P. Olszynski P. Geusens C. Kasibhatla N. Alsayed G. Isaia M. W. Davie C. H. Chesnut III 《Osteoporosis international》2002,13(6):501-505
Risedronate treatment reduces the risk of vertebral fracture in women with existing vertebral fractures, but its efficacy
in prevention of the first vertebral fracture in women with osteoporosis but without vertebral fractures has not been determined.
We examined the risk of first vertebral fracture in postmenopausal women who were enrolled in four placebo-controlled clinical
trials of risedronate and who had low lumbar spine bone mineral density (BMD) (mean T-score =–3.3) and no vertebral fractures at baseline. Subjects received risedronate 5 mg (n= 328) or placebo (n= 312) daily for up to 3 years; all subjects were given calcium (1000 mg daily), as well as vitamin D supplementation (up
to 500 IU daily) if baseline serum 25-hydroxyvitamin D levels were low. The incidence of first vertebral fracture was 9.4%
in the women treated with placebo and 2.6% in those treated with risedronate 5 mg (risk reduction of 75%, 95% confidence interval
37% to 90%; P= 0.002). The number of patients who would need to be treated to prevent one new vertebral fracture is 15. When subjects were
stratified by age, similar significant reductions were observed in patients with a mean age of 64 years (risk reduction of
70%, 95% CI 8% to 90%; P= 0.030) and in those with a mean age of 76 years (risk reduction of 80%, 95% CI 7% to 96%; P= 0.024). Risedronate treatment therefore significantly reduces the risk of first vertebral fracture in postmenopausal women
with osteoporosis, with a similar magnitude of effect early and late after the menopause.
Received: 12 September 2001 / Accepted: 11 December 2001 相似文献